Bringing the fundamentals into focus…
Back to CG Oncology, Inc.
How CG Oncology, Inc. stacks up
CGON · against 219 other Healthcare companies of similar size
Overall
52/ 100
Below the middle of the pack.
Ranked #126 of 220 · scores higher than 41% of peers
Bars: peers in each 10-point band of the overall score50 peers with an overall score of 50–59, including CGON · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CGON| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 3 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 4 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 5 | 40.3B SEK (≈$4.0B) | 79 | 43 | 84 | 97 | 0 / 2 | |
| 122 | 3.1B USD | 53 | 36 | 83 | 42 | 1 / 2 | |
| 122 | 5.6B USD | 53 | 33 | — | 25 | 0 / 2 | |
| 122 | 41.9B SEK (≈$4.2B) | 53 | 57 | 91 | 61 | 2 / 2 | |
| 126 | 427.8B JPY (≈$2.9B) | 52 | 77 | 59 | 60 | 2 / 2 | |
| 126 | 5.7B USD | 52 | 8 | 96 | 5 | 0 / 2 | |
| 126 | 5.1B USD | 52 | 42 | 85 | 47 | 2 / 2 | |
| 126 | 4.8B USD | 52 | 69 | 51 | 66 | 2 / 2 | |
| 126 | 9.7B AUD (≈$6.4B) | 52 | 84 | 40 | 58 | 2 / 2 | |
| 126 | 3.9B USD | 52 | 8 | 91 | 13 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score